U.S. General Merchandise and Department Stores Stock News

SEALSQ guidance and quantum roadmap draw investor focus SEALSQ (LAES) has reaffirmed its 2026 revenue guidance of 50% to 100% growth on audited 2025 revenue of US$18.3 million, while pushing ahead with its post-quantum cryptography product and readiness strategy. See our latest analysis for SEALSQ. Despite SEALSQ’s guidance reaffirmation and progress on its post quantum roadmap, the stock’s recent momentum has cooled, with the share price down 12.5% over 30 days and the year to date share...

MercadoLibre’s share price has delivered a 61.7% gain over the past three years, yet its valuation signals are pulling in different directions, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while market multiples suggest the stock trades at a premium. A 61.7% return over three years suggests MercadoLibre has already rewarded investors who stayed the course. This naturally raises the bar for what counts as good value today. Recent coverage...

With inflation, interest rate debates and energy shocks all pulling markets in different directions, investors are looking for clearer, more focused ideas. The AI Small Caps screener targets smaller companies that are building early-stage tools in areas such as machine learning, automation and data intelligence. These companies are at a stage where growth potential can still be influenced by new products and adoption. This article highlights 3 stocks from that screener, giving you a curated...

Aurinia Pharmaceuticals (AUPH) is drawing fresh attention after announcing PRESERVE, a Phase 4 multicenter study testing its oral lupus nephritis drug LUPKYNIS alongside three established immune therapies. See our latest analysis for Aurinia Pharmaceuticals. The PRESERVE announcement comes after a strong period for Aurinia Pharmaceuticals, with a 1 year total shareholder return of 113.70% and a more moderate 5.67% year to date share price return. This suggests momentum that investors are now...

On 27 June 2026, Lamar Advertising was added to multiple Russell value indices and benchmarks, while being removed from the Russell 1000 Dynamic Index, reshaping its index footprint across value and mid-cap segments. This broad inclusion across Russell value and defensive indices can meaningfully influence how institutional investors classify Lamar within portfolios focused on value-oriented real estate exposure. We’ll now examine how Lamar’s expanded presence in major Russell value indices...

Global protein markets are being shaken by the Trump administration’s decision to exempt Brazilian beef from proposed 25% tariffs, and that ripple is reaching well beyond ranches. For investors, this kind of trade shock can quickly reshuffle pricing power, costs and demand across traditional meat producers and consumer protein alternatives. This article breaks down three stocks exposed to the news, highlighting one that could see a potential tailwind from shifting consumer preferences and two...

On 27 June 2026, Blue Bird Corporation was removed from several Russell Microcap and Russell 3000E benchmarks while being added to the Russell 2000 Defensive and Russell 2000 Growth-Defensive indices, reshaping its index footprint across the small-cap universe. This reshuffling across growth, microcap, and defensive indices may alter how institutional investors view Blue Bird’s profile, positioning it more squarely within defensive-oriented small-cap mandates. We’ll now examine how Blue...

Recent commentary on Medpace Holdings (MEDP) focuses less on headline growth and more on the composition of its $2.93b backlog, as shifting cancellation patterns reshape how investors view its revenue visibility. See our latest analysis for Medpace Holdings. Medpace Holdings' recent share price has been volatile, with the stock falling 3.33% on the day to $546.29 but showing a 20.26% 1 month share price return. The 1 year total shareholder return of 69.39% and 5 year total shareholder return...

Clean energy and advanced nuclear are back in the spotlight after Google, XTX Markets and others backed a €400mn funding round in fusion start-up Proxima Fusion, valuing it at €2.4bn. For investors, that kind of commitment from major tech and energy companies signals fresh attention on businesses tied to next generation power, data centers and supporting infrastructure. This article breaks down 3 stocks that appear positively exposed to this fusion driven news, helping you think through where...

In the past quarter, Cadre Holdings (NYSE: CDRE) reported a 19.5% year-on-year revenue increase and earnings per share ahead of analyst estimates, with CEO Warren Kanders citing strong momentum extending into 2026. Despite these solid operating results, the reaction suggests investors had set a high bar for performance and outlook, highlighting how expectations can shape the interpretation of even upbeat earnings. Next, we’ll examine how Cadre’s earnings beat and CEO’s comments on momentum...

On 27 June 2026, TIC Solutions, Inc. (NYSE:TIC) was removed from multiple Russell indexes, including the Russell 2000 Defensive, 2500 Growth, 3000E Growth, and several growth-defensive and value-defensive benchmarks. This broad index exclusion reduces automatic index-linked ownership of TIC shares and may change how both passive and active investors view the company’s profile. We’ll now examine how TIC Solutions’ removal from several key Russell benchmarks shapes the company’s existing...

Covista (CVSA) stock is drawing attention after the company and Advocate Health unveiled a new nursing education and employment pathway that links scholarships, clinical training, and loan support to workforce needs. See our latest analysis for Covista. The partnership news arrives while momentum in Covista's stock has been building, with a 29.75% year to date share price return and a 263.40% three year total shareholder return that together point to sustained investor interest. If this shift...

In June 2026, AnaptysBio, Inc. was removed from several Russell indices, including the Russell Microcap, Russell 3000E, and related growth benchmark indices, triggering index rebalancing by passive funds. This broad removal from key Russell benchmarks may influence how investors perceive AnaptysBio’s visibility, liquidity, and role within the small-cap biotech universe. We’ll now examine how AnaptysBio’s exit from multiple Russell indices shapes its investment narrative, especially around...

Tariff headlines are back at the center of the market conversation, with President Trump pushing for broad new charges on imports from the EU and dozens of other countries, while legal challenges and rising costs for businesses add to the uncertainty. For investors, that kind of policy volatility tends to reward close attention to companies most exposed to shifting trade rules and imported inputs. This article breaks down three stocks from the Tariff Exposure Plays Amid Volatile US Trade...

In late June 2026, Flywire Corporation (NasdaqGS: FLYW) was added to the Russell 2000 Defensive, Growth-Defensive, and Value-Defensive indexes. This inclusion places Flywire on the radar of index-tracking funds and asset managers that follow Russell’s defensive and style-focused small-cap benchmarks. Next, we’ll explore how Flywire’s addition to multiple Russell 2000 defensive-style indexes may influence its broader investment narrative. Rare earth metals are the new gold rush. Find out...

Fresh coverage on Bentley Systems (BSY) is drawing attention after BNP Paribas and Bank of America highlighted the company as a potential defensive AI play, citing structural advantages in its core infrastructure software markets. See our latest analysis for Bentley Systems. Despite fresh coverage, Bentley Systems’ recent share price performance has been mixed, with the stock down about 7% over the past 90 days and the 1 year total shareholder return declining around 42%. This underlines why...

Recently, TransDigm Group reported quarterly earnings of US$9.85 per share, surpassing consensus forecasts, while analysts highlighted its strong record of outperforming expectations and its high-margin, recurring aftermarket aerospace revenue base. An interesting angle is that analysts are increasingly focusing on TransDigm’s proprietary components and recurring aftermarket cash flows as key supports for its earnings resilience. We’ll now examine how this increasingly bullish earnings...

Index removal puts Innoviva in focus Innoviva (INVA) has just been dropped from several Russell growth and small cap benchmarks. This type of change can prompt index-tracking funds to rebalance and may lead to increased short term trading activity in the stock. See our latest analysis for Innoviva. At a share price of US$22.25, Innoviva has seen mixed momentum, with the share price return up 11.98% year to date but down over the past quarter. Longer term total shareholder returns of 16.74%...

The Greenbrier Companies, Inc. recently reported third-quarter 2026 results showing revenue of US$576.5 million and net income of US$18.9 million, both lower than the same period a year earlier, alongside weaker earnings per share from continuing operations. Despite softer earnings and the completion of a long-running buyback program, management affirmed a quarterly dividend of US$0.34 per share, signaling confidence while balancing shareholder returns with current operating conditions. With...

Aeva Technologies (AEVA) has been in focus after advancing its 4D LiDAR into production programs, delivering Atlas sensors to Daimler Truck for a planned 2027 autonomous semi launch, and securing commercial vehicle and smart-city contracts. See our latest analysis for Aeva Technologies. Aeva Technologies' recent commercial wins sit against a sharp pullback in the 1-day and 7-day share price returns. However, the 90-day and year-to-date share price returns are firmly positive, and the 3-year...

RadNet (RDNT) is back in focus after its DeepHealth subsidiary commercially launched Reporting Pro, an AI powered radiology tool that combines speech recognition, AI generated findings, and quality checks within a single workflow. See our latest analysis for RadNet. Despite a 1-day share price return that declined 1.6% to about US$67.83, RadNet has seen strong short term momentum with a 7-day share price return of 10% and a 30-day share price return of 24.8%. The 1-year total shareholder...

Oil price shocks, higher Treasury yields and renewed tension around key shipping lanes are putting inflation back in focus for dividend investors. When inflation risks stay in the headlines, some look to large, essential businesses with a record of paying steady income. This article breaks down how the latest U.S. and Iran developments connect to that idea and what they might mean for investors who care about cash flow and resilience. Below, you will find three stocks from an...

In late June 2026, Marriott Vacations Worldwide Corporation (NYSE: VAC) was removed from both the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, prompting index-tracking funds to reconsider their positions. This dual index removal highlights how changes in benchmark composition can rapidly alter a company’s ownership base and influence how investors assess its role in portfolios. Next, we’ll examine how Marriott Vacations Worldwide’s removal from key Russell...

Index additions put Indivior Pharmaceuticals in the spotlight Indivior Pharmaceuticals (INDV) has been added to the Russell 2000 Growth-Defensive, Value-Defensive, and Defensive indices, an event that can influence trading activity as index funds adjust their holdings. See our latest analysis for Indivior Pharmaceuticals. At a share price of US$40.83, Indivior Pharmaceuticals has seen a 90 day share price return of 27.83% and a 1 year total shareholder return of 169.15%. This suggests...